Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Michael Grosse to Succeed Joachim Kreuzburg as Sartorius CEO (2024-12-06)
Grosse to take over as Group CEO on July 1, 2025 At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from Dr. Joachim Kreuzburg, who wil...
IonOpticks: Custom Chromatography Columns for Biognosys (2024-12-05)
Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys wi...
Antag Therapeutics Closes €80m Series A Led by Versant (2024-12-04)
> Round led by Versant Ventures with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet > Entering Phase I testing for next-generation weight loss therapy by antagonizing GIPR Antag Therapeutics, a next-ge...
Abselion (HexagonFab): £6.6m Series A Led by M Ventures (2024-12-04)
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 ...
Ipsen Licenses MAIT Cell Engager from Biomunex, up to $610m (2024-12-03)
> Ipsen secures exclusive global rights to develop, manufacture and commercialize BMX-502, a pre-clinical novel T cell engager (TCE) with first-in-class potential > BMX-502 is a bispecific antibody engaging MAIT cells, a subset of non-conventional T cells, and t...
Orbit Discovery & Evergreen Theragnostics Expand Collab (2024-12-03)
Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, today announced an extension to their research collaboration to find novel targeting peptides for r...
Gilead & Tubulis: up to $465m ADC Option & Licence Agreement (2024-12-03)
> Single-Asset Focused Collaboration, License, and Option Agreement Combines Tubulis’ Differentiated ADC Platform Technologies with Gilead’s Oncology Research and Development Expertise > Agreement Provides Gilead with Exclusive Option to License the Resultin...
Novartis Licenses Huntington Drug from PTC for up to $2.9b (2024-12-02)
> PTC to receive $1.0B in cash at closing > PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones > PTC to share profits in the U.S. and tiered double-digit royalties on ex-U.S. net sales > Novartis will assume global devel...
Mainz Biomed Announces 1-for-40 Reverse Stock Split (2024-11-29)
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a 1-for-40 reverse stock split of its issued and outstanding shares. The reverse stock...
Evotec: Craig Johnstone Steps Down as COO at End of 2024 (2024-11-29)
> Distribution of responsibilities internally Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave the Company effective 31 Decemb...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]